Daniel D Burgess Net Worth & Insider Trades

Daniel D Burgess - Director, Nabriva Therapeutics Plc

As of August 2, 2018

What is Daniel D Burgess's Net Worth?

The current estimated net worth of Nabriva Therapeutics Plc's Director, Daniel D Burgess, is estimated to be about $28.47K . Daniel D Burgess owns about 36,000 units of Nabriva Therapeutics Plc common stock. Recently at Nabriva Therapeutics Plc, Daniel D Burgess has sold an estimated value of $0 worth.

What is Daniel D Burgess's Past Insider Trading?

Daniel D Burgess's largest purchase order was 36,000 units , worth over $99K on August 2, 2018. In total, Daniel D Burgess has made about 1 transaction recently at Nabriva Therapeutics Plc. Daniel D Burgess usually trades in August, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Daniel D Burgess's' Mailing Address?

  • Mailing address is C/o Hollis-Eden Pharmaceuticals 4435 Eastgate Mall Ste.400 San Diego CA 92121 CA

Nabriva Therapeutics Plc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Theodore Schroeder 2020 $576,800 - $242,256 $339,625 $242,256 $31,759 $1,654,570
Theodore Schroeder 2019 $560,000 - $119,250 $478,367 $119,250 $28,372 $1,496,164
Steven Gelone 2020 $486,300 - $153,185 $231,493 $153,185 $12,675 $1,154,516
Steven Gelone 2019 $472,100 - $181,420 $309,859 $181,420 $13,976 $1,178,280
Jennifer Schranz 2020 $460,000 $100,000 $145,203 $156,818 $145,203 $28,604 $1,074,113
Jennifer Schranz 2019 $436,200 - $151,200 $261,555 $151,200 $33,450 $982,155
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm

What are Nabriva Therapeutics Plc's Past Insider Trades?

Nabriva Therapeutics Plc's most recent insider trade came on August 4, 2022 by Daniel Burgess who sold 11,341 units worth $2.16K . In the last 5 years, insiders at Nabriva Therapeutics Plc have sold an estimated value of $5.26M and bought an estimated value of $1.22M worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Steven Gelone, President and COO,  Theodore Schroeder, Chief Executive Officer,  and Robert Crotty, Gen Counsel & Corp Secretary .

Nabriva Therapeutics Legacy plc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1